In conclusion, by studying disease- and genetic-related phenotypes at the human cellular level, this study provided one possible hypothesis on how ASTN2, a candidate cross-disorder risk variant for psychiatric disorders, is involved in the pathogenesis of these disorders and throws new insights into the understanding of their molecular and cellular mechanisms. This evidence concerns the gene ASTN2 and psychiatric disorder.